SteriPack Awarded $14.743M Contract from U.S. DoD
SteriPack has received a $14.743 million contract to develop production capability for XpressCollect used in diagnostic testing for COVID-19.
Read MorePosted by Chris Wolski | Aug 27, 2021 | Covid 19 |
SteriPack has received a $14.743 million contract to develop production capability for XpressCollect used in diagnostic testing for COVID-19.
Read MorePosted by Chris Wolski | Aug 26, 2021 | Covid 19, Rapid Assays |
BD has announced the U.S. FDA has issued an Emergency Use Authorization (EUA) for the BD Veritor At-Home COVID-19 Test.
Read MorePosted by Chris Wolski | Aug 25, 2021 | Rapid Assays |
New England Biolabs (NEB) has released its newest loop-mediated isothermal amplification (LAMP) products, allowing for rapid, high throughput tests.
Read MorePosted by Chris Wolski | Aug 19, 2021 | Cancer |
llumina, Inc. has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers.
Read MorePosted by Chris Wolski | Aug 19, 2021 | Kidney Disease |
Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a protein in the urine test.
Read More